EMEA-002547-PIP01-19

Key facts

Active substance
Human chorionic gonadotrophin
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0283/2019
PIP number
EMEA-002547-PIP01-19
Pharmaceutical form(s)
Powder and solvent for solution for injection
Condition(s) / indication(s)
Treatment of female infertility
Route(s) of administration
  • Intramuscular use
  • Subcutaneous use
Contact for public enquiries
Regulis Consulting Europe Ltd

E-mail: regulatory@regulis.com
Tel. +44(0) 1442 890909

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating